3DPTimes — One World Printed Together

Login Signup

Home > Applications

Beyamedical Completes Series A+ Financing, Offering Personalized 3D-Printed Regenerative Implant Products

September 28, 2025 Applications 252

Chengdu Beya Medical, leveraging its proprietary osteoinduction technology and 3D printing platform, has secured a Series A+ investment to advance its personalized regenerative implants.

Chengdu Beya Medical Technology Co., Ltd. recently secured Series A+ investment from Huaxi Securities, with the amount undisclosed. According to an announcement by Huaxi Securities, Beya Medical successfully obtained funding support through the Chengdu High-tech Zone's policy-based equity-debt linkage product "Stock-Bond Connect" with assistance from multiple institutions.

Chengdu Beya Medical Secures Series A+ Investment via Innovative "Stock-Bond Connect" Financing

Chengdu Beya Medical Technology Co., Ltd. recently secured Series A+ investment from Huaxi Securities, with the specific amount undisclosed. According to an announcement by Huaxi Securities, Beya Medical successfully obtained funding support through the Chengdu High-tech Zone's policy-based "Stock-Bond Connect" product, an equity-debt linkage mechanism, with assistance from multiple institutions.

The "Stock-Bond Connect" program provides financing support to companies through a combination of debt and equity:

Debt Financing: Provided by Bank of Chengdu, offering credit funds of up to 50 million RMB with a maximum term of three years.

Equity Investment: Huaxi Securities participates in the form of equity investment, establishing a shareholder relationship with the company. It collaborates with institutions like Chengdu SME Financing Guarantee and High-Tech Investment Guarantee to share risks.

Follow-up Support: Companies can receive special subsidies and subsequent follow-up investments from equity investment funds, which helps reduce their debt-to-asset ratio and advance their listing process.

Founded in 2019, Chengdu Beya Medical is a high-tech enterprise focused on developing novel bioactive medical materials based on the globally original Osteoinduction Theory. These materials can induce tissue regeneration. The company also provides a R&D platform for precise digital medical services to healthcare institutions. It leverages the technical resources of the National Engineering Research Center for Biomaterials of Sichuan University and is led by its Chief Scientist, Professor Fan Yujiang of Sichuan University, an expert in the field of biological 3D printing.

Beya Medical is dedicated to integrating digital medical technologies with medical additive manufacturing (3D printing). It aims to build a comprehensive, customized, and precise digital medical service platform. This fully open platform offers holistic solutions and services to medical institutions and individuals. Its core product development centers on novel, precise implantable materials that can induce bone regeneration. The product portfolio also includes personalized digital medical models, surgical and radiotherapy assistive devices, rehabilitation braces, and personalized osteoinductive regenerative repair implants.

The company's current production lines cover various fields, including orthopedics, dentistry, medical aesthetic plastic surgery, oncology and neurosurgery, and rehabilitation. It provides patients with personalized regenerative implant products and comprehensive solutions.